SCHEMBL8330458

SCHEMBL8330458

COc1ccc(CN(C[C@H](O)[C@H](Cc2ccccc2)N(C(=O)OCc2ccccn2)C(=O)[C@@H](N)C(C)C)NC(=O)OCc2cccnc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
UGT1A1 P22309 3/20 0.37
MLNR O43193 1/20 0.37
NR1I2 O75469 1/20 0.37
SLCO2B1 O94956 1/20 0.37
ABCB11 O95342 1/20 0.37
ABCB1 P08183 1/20 0.37
CCKAR P32238 1/20 0.37
OPRK1 P41145 1/20 0.37
GHSR Q92847 1/20 0.37
SLCO1B3 Q9NPD5 1/20 0.37
ABCG2 Q9UNQ0 1/20 0.37
SLCO1B1 Q9Y6L6 1/20 0.37
KCNH2 Q12809 1/20 0.37
CTSD P07339 1/20 0.34
MAOB P27338 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC7 Q8WUI4 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7331827 0.95 CYP3A4 (0.41) CYP3A4UGT1A1MLNRNR1I2SLCO2B1
SCHEMBL7334217 0.90 UGT1A1 (0.41) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7332205 0.86 PGR (0.36) CYP3A4ABCB1MAOBALDH1A1HTT
SCHEMBL8331514 0.84 UGT1A1 (0.41) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7329645 0.81 UGT1A1 (0.38) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7336658 0.80 PGR (0.41) UGT1A1ABCB1KCNH2MAOBACACB
SCHEMBL7333582 0.78 UGT1A1 (0.36) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7275895 0.78 PGR (0.47) ABCB1MAOBACACBPGRADORA3
SCHEMBL7268965 0.78 CYP3A4 (0.46) CYP3A4ABCB1ACACBSLC1A5GPR132
SCHEMBL6447678 0.77 PGR (0.46) ABCB1MAOBACACBPGRADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed